<https://rdf.molmedb.upol.cz/reference/ref1087> <http://purl.org/dc/terms/subject> <https://rdf.molmedb.upol.cz/transporter/target69>,
		<https://identifiers.org/molmedb/MM01382>,
		<https://identifiers.org/molmedb/MM17284>,
		<https://identifiers.org/molmedb/MM00305>;
	<http://purl.org/ontology/bibo/doi> "10.1021/jm9506433"^^<http://www.w3.org/2001/XMLSchema#string>;
	<http://purl.org/dc/terms/bibliographicCitation> "Klein JT, Davis L, Olsen GE, Wong GS, Huger FP, Smith CP, Petko WW, Cornfeldt M, Wilker JC, Blitzer RD, Landau E, Haroutunian V, Martin LL, Effland RC.: Synthesis and structure-activity relationships of N-propyl-N-(4-pyridinyl)-1H-indol-1-amine (besipirdine) and related analogs as potential therapeutic agents for Alzheimer's disease. J Med Chem, Volume 39 (2), 1996"^^<http://www.w3.org/2001/XMLSchema#string>;
	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/dc/terms/BibliographicResource>;
	<http://purl.org/dc/terms/subject> <https://identifiers.org/molmedb/MM16833>;
	<http://purl.org/ontology/bibo/pmid> "8558529"^^<http://www.w3.org/2001/XMLSchema#string>;
	<http://purl.org/dc/terms/subject> <https://identifiers.org/molmedb/MM00344> .
<https://rdf.molmedb.upol.cz/transporter/tra56946> <http://www.w3.org/ns/prov#hadPrimarySource> <https://rdf.molmedb.upol.cz/reference/ref1087> .
<https://rdf.molmedb.upol.cz/transporter/tra58280> <http://www.w3.org/ns/prov#hadPrimarySource> <https://rdf.molmedb.upol.cz/reference/ref1087> .
<https://rdf.molmedb.upol.cz/transporter/tra58987> <http://www.w3.org/ns/prov#hadPrimarySource> <https://rdf.molmedb.upol.cz/reference/ref1087> .
<https://rdf.molmedb.upol.cz/transporter/tra58528> <http://www.w3.org/ns/prov#hadPrimarySource> <https://rdf.molmedb.upol.cz/reference/ref1087> .
<https://rdf.molmedb.upol.cz/transporter/tra57529> <http://www.w3.org/ns/prov#hadPrimarySource> <https://rdf.molmedb.upol.cz/reference/ref1087> .
